175-96-2 Usage
Uses
Used in Coordination Chemistry:
2,7-Diaza-spiro[4.4]nonane is used as a chelating ligand for forming stable complexes with metals such as copper and nickel. Its ability to bind with these metals is crucial in coordination chemistry, where it contributes to the development of new compounds with specific properties.
Used in Catalysis:
In the field of catalysis, 2,7-Diaza-spiro[4.4]nonane is utilized as a component in the design of catalysts. Its interaction with metals can enhance the catalytic activity of these systems, making it a valuable asset in chemical reactions.
Used in Material Development:
2,7-DIAZA-SPIRO[4.4]NONANE is also used in the development of new materials. Its unique structure and ability to form complexes with metals can lead to the creation of materials with novel properties, which can be applied in various industries.
Used in Medicinal Chemistry:
2,7-Diaza-spiro[4.4]nonane is used as a potential medicinal compound for its ability to inhibit the growth of certain cancer cells. Its biological activity makes it a candidate for further research and development in the pharmaceutical industry, particularly for anticancer applications.
Used in Cancer Research:
In cancer research, 2,7-Diaza-spiro[4.4]nonane is studied for its potential as an anticancer agent. Its ability to inhibit the growth of specific cancer cells suggests that it could be a valuable component in the development of new cancer treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 175-96-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,7 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 175-96:
(5*1)+(4*7)+(3*5)+(2*9)+(1*6)=72
72 % 10 = 2
So 175-96-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H14N2/c1-3-8-5-7(1)2-4-9-6-7/h8-9H,1-6H2
175-96-2Relevant academic research and scientific papers
NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES
-
Page/Page column 90, (2008/06/13)
The invention provides compounds of general formula (I) wherein A, B, p, w, x, y, and z are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Quinolone Antibacterial Agents Substituted at the 7-Position with Spiroamines. Synthesis and Structure-Activity Relationships
Culbertson, Townley P.,Sanchez, Joseph P.,Gambino, Laura,Sesnie, Josephine A.
, p. 2270 - 2275 (2007/10/02)
A series of fluoroquinolone antibacterials having the 7-position (10-position of pyridobenzoxazines) substituted with 2,7-diazaspirononane (4b), 1,7-diazaspirononane (5a), or 2,8-diazaspiroundecane (6b) was prepared, and their biological activities were compared with piperazine and pyrrolidine substituted analogues.Most exhibited potent Gram-positive and Gram-negative activity, especially when side chain 4b was N-alkylated.
